Table 3.

Performance of the proposed biomarker and the 50 blind-tested models. The concordance index (CI) and the logrank-test ${\chi }^2$ $p$-value were obtained from the risk analysis, the other measures via classification.

	Mean accuracy (95% C.I.)	Mean sensitivity (95% C.I.)	Mean specificity (95% C.I.)	Mean AUC (95% C.I.)	CI	Logrank-test ${\chi }^2$$p$-value
Proposed biomarker	0.96 (0.84–1)	0.96 (0.75–1)	0.96 (0.82–1)	0.97 (0.87–1)	0.74	$4.53{\mathrm{e}}^{-8}$
50 models (train)	0.99 (0.94–1)	0.99 (0.96–1)	0.99 (0.9–1)	1 (1–1)	–	–
50 models (test)	0.79 (0.6–1)	0.85 (0.5–1)	0.7 (0–1)	0.79 (0.4–1)	–	–